Chromogranin A as a predictor of radiological disease progression in neuroendocrine tumours

BACKGROUND: Chromogranin A (CgA) is the best established neuroendocrine biomarker. This study was aimed at investigating the prognostic value of CgA as a predictor of radiological disease progression in neuroendocrine tumour (NET) patients. METHODS: Patients with metastatic NETs and evidence of radi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Ann Transl Med
Päätekijät: Rossi, Roberta Elisa, Garcia-Hernandez, Jorge, Meyer, Tim, Thirlwell, Christina, Watkins, Jennifer, Martin, Nicholas Guy, Caplin, Martyn Evan, Toumpanakis, Christos
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: AME Publishing Company 2015
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4481369/
https://ncbi.nlm.nih.gov/pubmed/26207246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2305-5839.2015.04.23
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia